US5625041A
(en)
|
1990-09-12 |
1997-04-29 |
Delta Biotechnology Limited |
Purification of proteins
|
GB9019919D0
(en)
|
1990-09-12 |
1990-10-24 |
Delta Biotechnology Ltd |
Purification of proteins
|
US2714586A
(en)
|
1951-06-25 |
1955-08-02 |
Phillips Petroleum Co |
Washing urea and thiourea containing adducts
|
JPS4983148A
(es)
|
1972-12-16 |
1974-08-09 |
|
|
US4302386A
(en)
|
1978-08-25 |
1981-11-24 |
The Ohio State University |
Antigenic modification of polypeptides
|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
US4757006A
(en)
|
1983-10-28 |
1988-07-12 |
Genetics Institute, Inc. |
Human factor VIII:C gene and recombinant methods for production
|
JPS60169498A
(ja)
|
1984-02-10 |
1985-09-02 |
Kyowa Hakko Kogyo Co Ltd |
成人t細胞白血病ウイルス抗原ペプチド誘導体
|
ATE72838T1
(de)
|
1985-04-12 |
1992-03-15 |
Genetics Inst |
Neue prokoagulierungsproteine.
|
GR860984B
(en)
|
1985-04-17 |
1986-08-18 |
Zymogenetics Inc |
Expression of factor vii and ix activities in mammalian cells
|
ES2052712T3
(es)
|
1987-04-09 |
1994-07-16 |
Delta Biotechnology Ltd |
Vector de levadura.
|
ES2076939T3
(es)
|
1987-08-28 |
1995-11-16 |
Novo Nordisk As |
Lipasa recombinante de humicola y procedimiento para la produccion de lipasas recombinantes de humicola.
|
GB8725529D0
(en)
|
1987-10-30 |
1987-12-02 |
Delta Biotechnology Ltd |
Polypeptides
|
IL88326A
(en)
|
1987-11-18 |
1993-03-15 |
Gist Brocades Nv |
Purification of serum albumin
|
US5075222A
(en)
|
1988-05-27 |
1991-12-24 |
Synergen, Inc. |
Interleukin-1 inhibitors
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
GB8909916D0
(en)
|
1989-04-29 |
1989-06-14 |
Delta Biotechnology Ltd |
Polypeptides
|
US5766883A
(en)
|
1989-04-29 |
1998-06-16 |
Delta Biotechnology Limited |
Polypeptides
|
FR2650598B1
(fr)
|
1989-08-03 |
1994-06-03 |
Rhone Poulenc Sante |
Derives de l'albumine a fonction therapeutique
|
US5073627A
(en)
|
1989-08-22 |
1991-12-17 |
Immunex Corporation |
Fusion proteins comprising GM-CSF and IL-3
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
GB8927722D0
(en)
|
1989-12-07 |
1990-02-07 |
British Bio Technology |
Proteins and nucleic acids
|
DE4000939A1
(de)
|
1990-01-15 |
1991-07-18 |
Brem Gottfried Prof Dr Dr |
Verfahren zur antikoerpergewinnung
|
JP3230091B2
(ja)
|
1990-06-25 |
2001-11-19 |
ウェルファイド株式会社 |
ヒト血清アルブミンの着色抑制方法
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
IL99552A0
(en)
|
1990-09-28 |
1992-08-18 |
Ixsys Inc |
Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
|
CA2058820C
(en)
|
1991-04-25 |
2003-07-15 |
Kotikanyad Sreekrishna |
Expression cassettes and vectors for the secretion of human serum albumin in pichia pastoris cells
|
US5264586A
(en)
|
1991-07-17 |
1993-11-23 |
The Scripps Research Institute |
Analogs of calicheamicin gamma1I, method of making and using the same
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
US5663060A
(en)
|
1992-04-07 |
1997-09-02 |
Emory University |
Hybrid human/animal factor VIII
|
ZA932522B
(en)
|
1992-04-10 |
1993-12-20 |
Res Dev Foundation |
Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens
|
DE4226971C2
(de)
|
1992-08-14 |
1997-01-16 |
Widmar Prof Dr Tanner |
Modifizierte Pilzzellen und Verfahren zur Herstellung rekombinanter Produkte
|
US5728553A
(en)
|
1992-09-23 |
1998-03-17 |
Delta Biotechnology Limited |
High purity albumin and method of producing
|
JP3095175B2
(ja)
|
1992-11-13 |
2000-10-03 |
アイデック ファーマシューティカルズ コーポレイション |
B細胞リンパ腫の治療のためのヒトbリンパ球限定分化抗原に対するキメラ抗体と放射能標識抗体の療法利用
|
CA2167580A1
(en)
|
1993-07-22 |
1995-02-02 |
Howard Y. Chen |
Expression of human interleukin-1.beta. in a transgenic animal
|
DE4343591A1
(de)
|
1993-12-21 |
1995-06-22 |
Evotec Biosystems Gmbh |
Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes
|
US6811773B1
(en)
|
1993-12-22 |
2004-11-02 |
Human Genome Sciences, Inc. |
Human monocyte colony inhibitory factor (M-CIF) polypeptides
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
GB9404270D0
(en)
|
1994-03-05 |
1994-04-20 |
Delta Biotechnology Ltd |
Yeast strains and modified albumins
|
US5773001A
(en)
|
1994-06-03 |
1998-06-30 |
American Cyanamid Company |
Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
|
US7597886B2
(en)
|
1994-11-07 |
2009-10-06 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
US5712374A
(en)
|
1995-06-07 |
1998-01-27 |
American Cyanamid Company |
Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
US5716808A
(en)
|
1995-11-09 |
1998-02-10 |
Zymogenetics, Inc. |
Genetic engineering of pichia methanolica
|
US5955349A
(en)
|
1996-08-26 |
1999-09-21 |
Zymogenetics, Inc. |
Compositions and methods for producing heterologous polypeptides in Pichia methanolica
|
GB9526733D0
(en)
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
US6509313B1
(en)
|
1996-02-28 |
2003-01-21 |
Cornell Research Foundation, Inc. |
Stimulation of immune response with low doses of cytokines
|
US5736383A
(en)
|
1996-08-26 |
1998-04-07 |
Zymogenetics, Inc. |
Preparation of Pichia methanolica auxotrophic mutants
|
CN1230997A
(zh)
|
1996-07-17 |
1999-10-06 |
津莫吉尼蒂克斯公司 |
甲醇毕赤酵母的转化
|
US6274305B1
(en)
|
1996-12-19 |
2001-08-14 |
Tufts University |
Inhibiting proliferation of cancer cells
|
US6605699B1
(en)
|
1997-01-21 |
2003-08-12 |
Human Genome Sciences, Inc. |
Galectin-11 polypeptides
|
US7053190B2
(en)
|
1997-03-07 |
2006-05-30 |
Human Genome Sciences, Inc. |
Secreted protein HRGDF73
|
US7196164B2
(en)
|
1997-07-08 |
2007-03-27 |
Human Genome Sciences, Inc. |
Secreted protein HHTLF25
|
US6506569B1
(en)
|
1997-05-30 |
2003-01-14 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR10
|
US5948609A
(en)
|
1997-12-03 |
1999-09-07 |
Carter; Daniel C. |
Oxygen-transporting albumin-based blood replacement composition and blood volume expander
|
EP1030931A4
(en)
|
1998-08-06 |
2004-05-26 |
Syntron Biores Inc |
URIC ACID TEST DEVICE HAVING A STABILIZED URICASE REACTIVE COMPOSITION
|
CA2356542A1
(en)
|
1998-12-23 |
2000-07-06 |
Human Genome Sciences, Inc. |
Peptidoglycan recognition proteins
|
GB9902000D0
(en)
|
1999-01-30 |
1999-03-17 |
Delta Biotechnology Ltd |
Process
|
DE60043021D1
(de)
|
1999-05-17 |
2009-11-05 |
Conjuchem Biotechnologies Inc |
Lang wirkende Peptidinhibitoren der Virusfusion mit Körperzellen bei viralen Infektionen
|
EP1178786A4
(en)
|
1999-05-21 |
2006-03-01 |
American Bioscience Inc |
PHARMACOLOGICALLY ACTIVE PROTEIN STABILIZING AGENTS; METHODS OF MANUFACTURE AND METHODS OF USE
|
DK1266006T3
(da)
|
2000-03-22 |
2006-01-16 |
Octagene Gmbh |
Fremstilling af rekombinante muteiner af blodkoagulationsfaktor VIII i humane cellelinier
|
EP1274720A4
(en)
|
2000-04-12 |
2004-08-18 |
Human Genome Sciences Inc |
ALBUMIN FUSED PROTEINS
|
AU2001288301A1
(en)
|
2000-08-18 |
2002-03-04 |
Human Genome Sciences, Inc. |
Binding polypeptides and methods based thereon
|
JP2005500806A
(ja)
|
2000-09-15 |
2005-01-13 |
コーリー ファーマシューティカル ゲーエムベーハー |
CpGに基づく免疫アゴニスト/免疫アンタゴニストの高スループットスクリーニングのためのプロセス
|
WO2002055110A2
(en)
|
2000-10-25 |
2002-07-18 |
Genzyme Corp |
Methods for treating blood coagulation disorders
|
US6992234B2
(en)
|
2000-11-06 |
2006-01-31 |
The Jackson Laboratory |
FcRn-based therapeutics for the treatment of auto-immune disorders
|
PL393178A1
(pl)
|
2000-12-07 |
2011-02-14 |
Eli Lilly And Company |
Heterogenne białko fuzyjne, kompozycja farmaceutyczna do leczenia pacjentów z cukrzycą insulino-niezależną i kompozycja farmaceutyczna do leczenia pacjentów z otyłością
|
US7175988B2
(en)
|
2001-02-09 |
2007-02-13 |
Human Genome Sciences, Inc. |
Human G-protein Chemokine Receptor (CCR5) HDGNR10
|
US7507413B2
(en)
|
2001-04-12 |
2009-03-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
ATE470676T1
(de)
|
2001-04-13 |
2010-06-15 |
Human Genome Sciences Inc |
Anti-vegf-2 antikörper
|
AUPR446701A0
(en)
|
2001-04-18 |
2001-05-17 |
Gene Stream Pty Ltd |
Transgenic mammals for pharmacological and toxicological studies
|
WO2002102830A1
(en)
|
2001-06-15 |
2002-12-27 |
New Century Pharmaceuticals, Inc. |
Human albumin animal models for drug evaluation, toxicology and immunogenicity studies
|
ATE375388T1
(de)
|
2001-07-27 |
2007-10-15 |
Us Gov Health & Human Serv |
Systeme zur stellengerichteten in-vivo-mutagenese mit oligonukleotiden
|
CN1405182A
(zh)
|
2001-08-10 |
2003-03-26 |
中国人民解放军军事医学科学院生物工程研究所 |
血清白蛋白与粒细胞集落刺激因子的融合蛋白
|
CA2841097A1
(en)
|
2001-12-21 |
2003-07-24 |
Human Genome Sciences, Inc. |
Albumin and g-csf fusion proteins
|
CA2484556A1
(en)
|
2001-12-21 |
2003-07-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US20080167238A1
(en)
|
2001-12-21 |
2008-07-10 |
Human Genome Sciences, Inc. |
Albumin Fusion Proteins
|
NZ579419A
(en)
|
2002-02-07 |
2011-02-25 |
Dyax Corp |
Albumin-fused kunitz domain peptides
|
US20080108560A1
(en)
|
2002-03-05 |
2008-05-08 |
Eli Lilly And Company |
Heterologous G-Csf Fusion Proteins
|
US6995933B1
(en)
|
2002-04-30 |
2006-02-07 |
Western Digital Technologies, Inc. |
Disk drive for optimizing write current settings relative to drive operating characteristics and ambient temperature readings
|
WO2003102136A2
(en)
|
2002-05-30 |
2003-12-11 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to neurokinin b
|
CN1241946C
(zh)
|
2002-07-01 |
2006-02-15 |
美国福源集团 |
对多种细胞具刺激增生作用的人血清白蛋白重组融合蛋白
|
GB0217347D0
(en)
|
2002-07-26 |
2002-09-04 |
Univ Edinburgh |
Novel albumins
|
CA2492457A1
(en)
|
2002-08-02 |
2004-02-12 |
Craig A. Rosen |
Antibodies against c3a receptor
|
WO2004058044A2
(en)
|
2002-11-19 |
2004-07-15 |
Drg International, Inc. |
Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
|
CA2513213C
(en)
|
2003-01-22 |
2013-07-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
ATE411819T1
(de)
|
2003-02-17 |
2008-11-15 |
Upperton Ltd |
Konjugate für medizinische abbildungen umfassend träger, targeting-anteile und kontrastmittel
|
GB0305989D0
(en)
|
2003-03-15 |
2003-04-23 |
Delta Biotechnology Ltd |
Agent
|
WO2004082640A2
(en)
|
2003-03-19 |
2004-09-30 |
New Century Pharmaceuticals, Inc. |
Human serum albumin conjugates with therapeutic compounds
|
US20070166711A1
(en)
|
2003-04-15 |
2007-07-19 |
Samuels Mark E |
Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
|
US20050079546A1
(en)
|
2003-05-01 |
2005-04-14 |
Dasa Lipovsek |
Serum albumin scaffold-based proteins and uses thereof
|
WO2005007121A2
(en)
|
2003-07-18 |
2005-01-27 |
Massachusetts Institute Of Technology |
Mutant interleukin-2(il-2) polypeptides
|
US20080308744A1
(en)
|
2003-11-18 |
2008-12-18 |
Beth Israel Deaconess Medical Center |
Serum Albumin Conjugated to Fluorescent Substances for Imaging
|
GB0329722D0
(en)
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Modified plasmid and use thereof
|
GB0329681D0
(en)
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Gene expression technique
|
US7166577B2
(en)
|
2003-12-26 |
2007-01-23 |
Nipro Corporation |
Albumin having enhanced antimicrobial activity
|
JP4649954B2
(ja)
|
2003-12-26 |
2011-03-16 |
ニプロ株式会社 |
抗菌作用が増強されたアルブミン
|
KR100671005B1
(ko)
|
2004-01-15 |
2007-01-18 |
고려대학교 산학협력단 |
Pah 노출 여부 진단용 바이오 마커 단백질
|
BRPI0507026A
(pt)
|
2004-02-09 |
2007-04-17 |
Human Genome Sciences Inc |
proteìnas de fusão de albumina
|
RU2369404C2
(ru)
*
|
2004-02-09 |
2009-10-10 |
Хьюман Дженом Сайенсиз, Инк. |
Слитые белки альбумина
|
JP4492156B2
(ja)
|
2004-03-03 |
2010-06-30 |
ニプロ株式会社 |
血清アルブミンドメインを含む蛋白質
|
US20060018859A1
(en)
|
2004-07-16 |
2006-01-26 |
Carter Daniel C |
Modified human serum albumin with reduced or eliminated affinity to chemical or biological contaminants at Cys 34
|
US20060051859A1
(en)
|
2004-09-09 |
2006-03-09 |
Yan Fu |
Long acting human interferon analogs
|
JP4948413B2
(ja)
|
2004-09-23 |
2012-06-06 |
ジェネンテック, インコーポレイテッド |
システイン操作抗体および結合体
|
US20090280534A1
(en)
|
2004-12-22 |
2009-11-12 |
Novozymes A/S |
Recombinant Production of Serum Albumin
|
EP2330200B1
(en)
|
2004-12-23 |
2017-04-05 |
Albumedix A/S |
Gene expression technique
|
WO2006073195A1
(ja)
|
2005-01-07 |
2006-07-13 |
Biomarker Science Co., Ltd |
糖尿病の予知・診断方法および糖尿病予知・診断用キット
|
US20060178301A1
(en)
|
2005-02-04 |
2006-08-10 |
Mathias Jurs |
Albumin-fused ciliary neurotrophic factor
|
EP1879920A2
(en)
|
2005-04-29 |
2008-01-23 |
The Jackson Laboratory |
Fcrn antibodies and uses thereof
|
GB0512707D0
(en)
|
2005-06-22 |
2005-07-27 |
Delta Biotechnology Ltd |
Gene expression technique
|
WO2007021494A2
(en)
|
2005-08-12 |
2007-02-22 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
CA2562249A1
(en)
|
2005-10-20 |
2007-04-20 |
University Of Ottawa Heart Institute |
Anf analogue
|
CA2634495A1
(en)
|
2005-12-22 |
2007-06-28 |
Conjuchem Biotechnologies Inc. |
Process for the production of preformed conjugates of albumin and a therapeutic agent
|
EP1816201A1
(en)
|
2006-02-06 |
2007-08-08 |
CSL Behring GmbH |
Modified coagulation factor VIIa with extended half-life
|
WO2007112940A2
(en)
|
2006-03-31 |
2007-10-11 |
Ablynx N.V. |
Albumin-derived amino acid sequence, use thereof for increasing the half-life of therapeutic proteins and of other therapeutic compounds and entities, and constructs comprising the same
|
EP2046367A4
(en)
|
2006-06-07 |
2009-11-11 |
Human Genome Sciences Inc |
ALBUM INFUSION PROTEINS
|
DK2256135T3
(da)
|
2006-06-14 |
2019-06-11 |
Csl Behring Gmbh |
Proteolytisk spaltbart fusionsprotein, der omfatter en blodkoagulationsfaktor
|
CA2657277C
(en)
|
2006-07-13 |
2015-11-24 |
Upperton Limited |
Process for preparing particles of proteinaceous material
|
JP4983148B2
(ja)
|
2006-08-18 |
2012-07-25 |
ニプロ株式会社 |
糖鎖含有アルブミン、その製造方法およびその用途
|
AU2007292903B2
(en)
|
2006-09-08 |
2012-03-29 |
Ambrx, Inc. |
Modified human plasma polypeptide or Fc scaffolds and their uses
|
US20100129846A1
(en)
|
2006-12-07 |
2010-05-27 |
Power3 Medical Products, Inc. |
Isoform specificities of blood serum proteins and their use as differentially expressed protein biomarkers for diagnosis of breast cancer
|
JP2010535484A
(ja)
|
2007-08-08 |
2010-11-25 |
ノボザイムス バイオファーマ デーコー アクティーゼルスカブ |
トランスフェリン変異体と複合体
|
WO2009061853A2
(en)
|
2007-11-05 |
2009-05-14 |
Massachusetts Institute Of Technology |
Mutant interleukin-2 (il-2) polypeptides
|
CA2611540C
(en)
|
2007-11-09 |
2017-05-30 |
Nipro Corporation |
Sugar chain-containing albumin as a drug carrier to the liver
|
MX343594B
(es)
|
2007-12-21 |
2016-11-11 |
Medimmune Ltd |
Miembros de union para receptor alfa de interleucina-4 (il-4ra) - 173.
|
CA2721093A1
(en)
|
2008-04-11 |
2009-10-15 |
Merrimack Pharmaceuticals, Inc. |
Human serum albumin linkers and conjugates thereof
|
US20110112040A1
(en)
|
2008-04-28 |
2011-05-12 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
JP2011528804A
(ja)
|
2008-07-18 |
2011-11-24 |
オラジェニックス,インコーポレイテッド |
結腸直腸癌の検出及び治療のための組成物
|
CN102282168A
(zh)
|
2008-11-18 |
2011-12-14 |
梅里麦克制药股份有限公司 |
人血清白蛋白接头以及其结合物
|
AU2009322126B2
(en)
|
2008-12-05 |
2013-06-20 |
Abraxis Bioscience, Llc |
Albumin binding peptide-mediated disease targeting
|
CN102307905B
(zh)
|
2008-12-10 |
2015-11-25 |
斯克利普斯研究院 |
利用化学反应性非天然氨基酸产生载体-肽偶联物
|
DK2396347T3
(en)
|
2009-02-11 |
2017-07-24 |
Albumedix As |
ALBUMIN VARIANTS AND CONJUGATES
|
CN102458442B
(zh)
|
2009-04-08 |
2016-06-29 |
加利福尼亚大学董事会 |
具有受控血清药代动力学的人蛋白支架
|
EP2424877A4
(en)
|
2009-04-28 |
2013-01-02 |
Harvard College |
SUPERCHARGED PROTEINS FOR CELL PENETRATION
|
US8232067B2
(en)
|
2009-05-29 |
2012-07-31 |
Brigham & Women's Hospital, Inc. |
Disrupting FCRN-albumin interactions
|
ES2548030T3
(es)
|
2009-06-01 |
2015-10-13 |
Medimmune, Llc |
Moléculas con semividas prolongadas y usos de las mismas
|
KR101286721B1
(ko)
|
2009-06-05 |
2013-07-16 |
한국과학기술연구원 |
폴리-시스테인 펩티드 융합 재조합 알부민 및 이의 제조방법
|
EP2456454A4
(en)
|
2009-07-20 |
2013-03-20 |
Univ Nat Cheng Kung |
FOR AV-3-INTEGRIN SELECTIVE POLYPEPTIDE AND PHARMACEUTICAL USES THEREOF ASSOCIATED WITH A HUMAN SERUM ALUMINUM (HSA) VARIATION
|
WO2011011797A2
(en)
|
2009-07-24 |
2011-01-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cytokine compositions and methods of use thereof
|
CA2770620A1
(en)
|
2009-08-10 |
2011-02-17 |
Mark Smith |
Thiol protecting group
|
US20110172398A1
(en)
|
2009-10-02 |
2011-07-14 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules for anti-angiogenesis therapy
|
KR20120093932A
(ko)
|
2009-10-10 |
2012-08-23 |
일레븐 바이오테라피틱스, 아이엔씨. |
Il-17 패밀리 사이토카인 조성물들 및 용도들
|
BR112012009450A2
(pt)
|
2009-10-30 |
2017-05-23 |
Novozymes Biopharma Dk As |
variantes de albumina
|
WO2011079175A1
(en)
|
2009-12-23 |
2011-06-30 |
National Cheng Kung University |
Compositions and methods for the treatment of angiogenesis-related eye diseases
|
CN101875693B
(zh)
|
2010-01-22 |
2012-07-18 |
成都正能生物技术有限责任公司 |
具备抗血管生成活性的白蛋白变异体及其制备方法
|
EP2536756B1
(en)
|
2010-02-16 |
2018-04-25 |
MedImmune, LLC |
Hsa-related compositions and methods of use
|
CN102939304B
(zh)
|
2010-04-09 |
2017-04-19 |
阿尔布麦狄克斯公司 |
白蛋白衍生物和变体
|
WO2011146902A1
(en)
|
2010-05-21 |
2011-11-24 |
Merrimack Pharmaceuticals, Inc. |
Bi-specific fusion proteins
|
WO2011161127A1
(en)
|
2010-06-21 |
2011-12-29 |
Medimmune, Llc |
Protease variants of human neprilysin
|
JP2013538566A
(ja)
|
2010-08-13 |
2013-10-17 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド |
改良された抗血清アルブミン結合変異体
|
US20130225496A1
(en)
*
|
2010-11-01 |
2013-08-29 |
Novozymes Biopharma Dk A/S |
Albumin Variants
|
KR20140012094A
(ko)
*
|
2011-02-15 |
2014-01-29 |
메디뮨 엘엘씨 |
Hsa 관련 조성물 및 사용 방법
|
US9045564B2
(en)
|
2011-02-15 |
2015-06-02 |
Medimmune, Llc |
HSA-related compositions and methods of use
|
JP5641536B2
(ja)
*
|
2011-03-15 |
2014-12-17 |
日本パーカライジング株式会社 |
固定砥粒ソーワイヤー用電着液
|
EP2705051A1
(en)
*
|
2011-05-05 |
2014-03-12 |
Novozymes Biopharma DK A/S |
Albumin variants
|
AU2012286048A1
(en)
|
2011-07-18 |
2014-02-20 |
Arts Biologics A/S |
Long acting luteinizing hormone (LH) compound
|
EP2780364A2
(en)
|
2011-11-18 |
2014-09-24 |
Eleven Biotherapeutics, Inc. |
Proteins with improved half-life and other properties
|
KR20140136934A
(ko)
|
2012-03-16 |
2014-12-01 |
노보자임스 바이오파마 디케이 에이/에스 |
알부민 변이체
|
WO2014005596A1
(en)
|
2012-07-03 |
2014-01-09 |
Aarhus Universitet |
Modified payload molecules and their interactions and uses
|
US8757798B2
(en)
|
2012-08-31 |
2014-06-24 |
Cody Air LLC |
Eyewear frame
|
KR20150082422A
(ko)
|
2012-11-08 |
2015-07-15 |
노보자임스 바이오파마 디케이 에이/에스 |
알부민 변이체
|
KR20150118123A
(ko)
|
2013-02-16 |
2015-10-21 |
노보자임스 바이오파마 디케이 에이/에스 |
약동학적 동물 모델
|
WO2014179657A1
(en)
|
2013-05-03 |
2014-11-06 |
Eleven Biotherapeutics, Inc. |
Albumin variants binding to fcrn
|
WO2015036579A1
(en)
|
2013-09-13 |
2015-03-19 |
Novozymes Biopharma Dk A/S |
Albumin variants
|
US10208102B2
(en)
|
2013-11-01 |
2019-02-19 |
University Of Oslo |
Albumin variants and uses thereof
|
CA2989966A1
(en)
|
2015-08-20 |
2017-02-23 |
Albumedix A/S |
Albumin variants and conjugates
|